Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma

Kurt M., Onal I., Elkiran T., Altun B., Altundag K., Gullu I.

MEDICAL ONCOLOGY, vol.22, no.2, pp.203-206, 2005 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 22 Issue: 2
  • Publication Date: 2005
  • Doi Number: 10.1385/mo:22:2:203
  • Journal Name: MEDICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.203-206


We report the case of a 52-yr-old man with metastatic lung adenocarcinoma who developed tumor lysis syndrome after administration of zoledronic acid. Tumor lysis syndrome in solid tumors and the antitumor effect of the zolendronic acid are discussed in light of the pertinent literature.